Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Care Coordination and Food Assistance Referrals to Improve Diabetes Outcomes: A Cohort Study.

Journal of general internal medicine·2026
Same author

Combining Observational Studies to Reduce Multiple Biases.

Epidemiology (Cambridge, Mass.)·2026
Same author

MVA.HIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.

The Journal of clinical investigation·2026
Same author

A Primer on Large-Sample Statistical Inference for Epidemiologists.

Epidemiologic methods·2026
Same author

Racial Differences in Expected Versus Actual Costs of Cervical Cancer Screening among Low-Income, Underscreened Women in North Carolina.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Comparative Effectiveness of Levonorgestrel Implant and Depot Medroxyprogesterone Acetate Injectable for Women Living With HIV on Dolutegravir-Based Antiretroviral Therapy.

Pharmacoepidemiology and drug safety·2026

Related Experiment Video

Updated: Jun 23, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Assessing vaccine effects in repeated low-dose challenge experiments.

Michael G Hudgens1, Peter B Gilbert

  • 1Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina 27599, USA. mhudgens@bios.unc.edu

Biometrics
|April 29, 2009
PubMed
Summary

Evaluating human immunodeficiency virus (HIV) vaccine efficacy in nonhuman primates (NHPs) is crucial. This study examines methods for assessing vaccine effectiveness using repeated low-dose challenges and potential immunological surrogate endpoints.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

Related Experiment Videos

Last Updated: Jun 23, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Nonhuman primates (NHPs) are vital models for evaluating human immunodeficiency virus (HIV) vaccine candidates.
  • Traditional HIV vaccine studies in NHPs used single high-dose viral challenges.
  • Current research increasingly employs repeated low-dose challenges to better simulate natural HIV transmission.

Purpose of the Study:

  • To analyze methods for evaluating the type and magnitude of vaccine efficacy in NHP models.
  • To explore the use of the principal stratification framework for analyzing vaccine efficacy data.
  • To address the evaluation of potential immunological surrogate endpoints for HIV infection in vaccine studies.

Main Methods:

  • Utilizing the principal stratification framework for statistical analysis.
  • Analyzing data from vaccine efficacy experiments involving repeated low-dose HIV challenges in NHPs.
  • Investigating potential immunological markers as surrogates for infection prevention.

Main Results:

  • The study provides a framework for assessing vaccine efficacy under more realistic challenge conditions.
  • It highlights the importance of considering the type and magnitude of protection offered by vaccine candidates.
  • The proposed methods can aid in the interpretation of results from NHP HIV vaccine trials.

Conclusions:

  • Evaluating HIV vaccine candidates in NHPs requires robust statistical frameworks to interpret efficacy.
  • Repeated low-dose challenge models offer a more relevant assessment of vaccine performance.
  • Identifying reliable immunological surrogate endpoints is key for accelerating HIV vaccine development.